Lifestance Health [LFST] vs HCA Healthcare [HCA] Detailed Stock Comparison
Lifestance Health
NASDAQ
Loading...
HCA Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lifestance Health wins in 4 metrics, HCA Healthcare wins in 14 metrics, with 0 ties. HCA Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lifestance Health | HCA Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -37.00 | 16.99 | Lifestance Health |
| Price-to-Book Ratio | 1.47 | -77.25 | HCA Healthcare |
| Debt-to-Equity Ratio | 32.18 | -37.45 | HCA Healthcare |
| PEG Ratio | 0.44 | 0.68 | Lifestance Health |
| EV/EBITDA | 41.49 | 9.96 | HCA Healthcare |
| Profit Margin (TTM) | -1.23% | 8.21% | HCA Healthcare |
| Operating Margin (TTM) | -0.85% | 15.95% | HCA Healthcare |
| EBITDA Margin (TTM) | N/A | 15.95% | N/A |
| Return on Equity | -1.11% | 13,631.68% | HCA Healthcare |
| Return on Assets (TTM) | 0.04% | 11.84% | HCA Healthcare |
| Free Cash Flow (TTM) | $85.69M | $5.64B | HCA Healthcare |
| Dividend Yield | N/A | 0.54% | N/A |
| 1-Year Return | -10.19% | 4.16% | HCA Healthcare |
| Price-to-Sales Ratio (TTM) | 1.64 | 1.30 | HCA Healthcare |
| Enterprise Value | $2.44B | $144.46B | HCA Healthcare |
| EV/Revenue Ratio | 1.86 | 1.99 | Lifestance Health |
| Gross Profit Margin (TTM) | 31.40% | 40.97% | HCA Healthcare |
| Revenue per Share (TTM) | $3 | $292 | HCA Healthcare |
| Earnings per Share (Diluted) | $-0.04 | $23.79 | HCA Healthcare |
| Beta (Stock Volatility) | 1.13 | 1.40 | Lifestance Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lifestance Health vs HCA Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lifestance Health | 0.91% | 2.02% | 32.14% | -1.42% | -26.88% | -26.49% |
| HCA Healthcare | 0.18% | 2.32% | 15.39% | 7.52% | 26.72% | 36.01% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lifestance Health | -10.19% | -15.14% | -76.88% | -76.88% | -76.88% | -76.88% |
| HCA Healthcare | 4.16% | 97.57% | 197.79% | 355.94% | 1,201.32% | 1,201.32% |
Performance & Financial Health Analysis: Lifestance Health vs HCA Healthcare
| Metric | LFST | HCA |
|---|---|---|
| Market Information | ||
| Market Cap | $2.16B | $94.59B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 3,662,190 | 1,175,558 |
| 90 Day Avg. Volume | 2,999,970 | 1,449,993 |
| Last Close | $5.55 | $404.97 |
| 52 Week Range | $3.74 - $8.61 | $289.98 - $417.14 |
| % from 52W High | -35.54% | -2.92% |
| All-Time High | $29.81 (Jul 05, 2021) | $417.14 (Oct 14, 2024) |
| % from All-Time High | -81.38% | -2.92% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.06% |
| Quarterly Earnings Growth | N/A | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | 0.08% |
| Operating Margin (TTM) | -0.01% | 0.16% |
| Return on Equity (TTM) | -0.01% | 136.32% |
| Debt to Equity (MRQ) | 32.18 | -37.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.79 | $-18.61 |
| Cash per Share (MRQ) | $0.49 | $4.45 |
| Operating Cash Flow (TTM) | $146.34M | $11.93B |
| Levered Free Cash Flow (TTM) | $121.32M | $5.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.54% |
| Last 12-Month Dividend | N/A | $2.04 |
Valuation & Enterprise Metrics Analysis: Lifestance Health vs HCA Healthcare
| Metric | LFST | HCA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -37.00 | 16.99 |
| Forward P/E | -32.65 | 16.47 |
| PEG Ratio | 0.44 | 0.68 |
| Price to Sales (TTM) | 1.64 | 1.30 |
| Price to Book (MRQ) | 1.47 | -77.25 |
| Market Capitalization | ||
| Market Capitalization | $2.16B | $94.59B |
| Enterprise Value | $2.44B | $144.46B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.86 | 1.99 |
| Enterprise to EBITDA | 41.49 | 9.96 |
| Risk & Other Metrics | ||
| Beta | 1.13 | 1.40 |
| Book Value per Share (MRQ) | $3.79 | $-18.61 |
Financial Statements Comparison: Lifestance Health vs HCA Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LFST | HCA |
|---|---|---|
| Revenue/Sales | $332.97M | $18.61B |
| Cost of Goods Sold | $223.18M | $10.98B |
| Gross Profit | $109.79M | $7.62B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $1.60M | $2.97B |
| EBITDA | $15.36M | $3.85B |
| Pre-Tax Income | $-1.47M | $2.42B |
| Income Tax | $-2.18M | $524.00M |
| Net Income (Profit) | $709,000 | $1.89B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LFST | HCA |
|---|---|---|
| Cash & Equivalents | $134.34M | $1.06B |
| Total Current Assets | $304.63M | $16.26B |
| Total Current Liabilities | $207.39M | $13.63B |
| Long-Term Debt | $425.71M | $42.92B |
| Total Shareholders Equity | $1.46B | $-438.00M |
| Retained Earnings | $-817.58M | $-3.16B |
| Property, Plant & Equipment | $148.91M | $65.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LFST | HCA |
|---|---|---|
| Operating Cash Flow | $23.35M | $2.65B |
| Capital Expenditures | $-7.17M | $-991.00M |
| Free Cash Flow | $-10.26M | $660.00M |
| Debt Repayment | $-1.81M | $-3.90B |
| Common Stock Repurchase | N/A | $-2.51B |
Short Interest & Institutional Ownership Analysis
| Metric | LFST | HCA |
|---|---|---|
| Shares Short | 7.41M | 4.06M |
| Short Ratio | 3.10 | 2.60 |
| Short % of Float | 0.09% | 0.02% |
| Average Daily Volume (10 Day) | 3,662,190 | 1,175,558 |
| Average Daily Volume (90 Day) | 2,999,970 | 1,449,993 |
| Shares Outstanding | 382.74M | 249.98M |
| Float Shares | 140.04M | 161.52M |
| % Held by Insiders | 0.08% | 0.31% |
| % Held by Institutions | 0.92% | 0.65% |
Dividend Analysis & Yield Comparison: Lifestance Health vs HCA Healthcare
| Metric | LFST | HCA |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.04 |
| Last 12-Month Dividend Yield | N/A | 0.54% |
| 3-Year Avg Annual Dividend | N/A | $2.29 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $6.88 |
| Ex-Dividend Date | N/A | Mar 17, 2025 |